Levetiracetam Solution
Product Images NDC 0121-4799

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 0121-4799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levetiracetam 01)

Chemical structure diagram of levetiracetam illustrating its molecular framework, including a pyrrolidone ring with various attached functional groups.*

FDA Label Image

Figure 1 (Levetiracetam 02)

A bar graph comparing the percentage of patients across three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The graph shows increased patient response percentages with higher doses of Levetiracetam.*

FDA Label Image

Figure 2 (Levetiracetam 03)

A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The y-axis represents the percentage of patients from 0% to 45%. The bars show 6.3% for Placebo, 20.8% for Levetiracetam 1000 mg/day (N=106), and 35.2% for Levetiracetam 2000 mg/day (N=105). Asterisks appear within the bars for Levetiracetam groups.*

FDA Label Image

Figure 3 (Levetiracetam 04)

A bar chart comparing the percentage of patients between two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The chart shows approximately 14.4% of patients in the Placebo group and 39.4% in the Levetiracetam group.*

FDA Label Image

Figure 4 (Levetiracetam 05)

A bar graph comparing the percentage of patients in two groups: Placebo (N=97) at 19.6% and Levetiracetam (N=101) at 44.6%. The y-axis represents the percentage of patients from 0% to 45%. An asterisk marks the Levetiracetam group bar.*

FDA Label Image

Figure 5 (Levetiracetam 06)

A bar graph comparing the percentage of patients responding to placebo versus Levetiracetam treatment. The graph shows approximately 19.6% response in the placebo group (N=51) and about 43.1% response in the Levetiracetam group (N=58), with a note indicating statistical significance between the two groups.*

FDA Label Image

Figure 6 (Levetiracetam 07)

A bar chart showing the percentage of patients in two groups, Placebo and Levetiracetam. The y-axis represents the percentage of patients, and the x-axis compares Placebo (N=84) at 45.2% and Levetiracetam (N=79) at 72.2%.*

FDA Label Image

Principal Display Panel (473 mL Bottle Label)

Label for Levetiracetam Oral Solution USP, 100 mg/mL, a human prescription drug by PAI Holdings, LLC dba PAI Pharma. The label indicates a 16 fl oz (473 mL) bottle with storage instructions, dispensing guidance, and a warning to keep out of reach of children. It includes the NDC 0121-0799-16 and pharmacist instructions for use in a child-resistant container.*

FDA Label Image

Principal Display Panel (5 mL Cup Label)

Levetiracetam Oral Solution, USP 500 mg/5 mL unit dose label delivering 5 mL solution. The label includes the NDC code 0121-4799-05 and is marked for prescription use only by Pharmaceutical Associates, Inc., Greenville, SC. It indicates the package is not child-resistant and advises to see the insert.*

FDA Label Image

Principal Display Panel (10 mL Cup Label)

Levetiracetam Oral Solution USP 1000 mg/10 mL single-dose container label. The label states it delivers 10 mL, includes the NDC 0121-1598-10, and bears a barcode. It notes the package is not child-resistant, is Rx only, and is manufactured by Pharmaceutical Associates, Inc. in Greenville, SC.*

FDA Label Image

Principal Display Panel (15 mL Cup Label)

Levetiracetam Oral Solution, USP 1500 mg per 15 mL single-dose vial label. The label includes the NDC 0121-2397-15, is marked as not child-resistant, prescription only, and produced by Pharmaceutical Associates, Inc., Greenville, SC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.